Business Description
Bausch Health Companies Inc
NAICS : 325412
SIC : 3741
ISIN : CA0717341071
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | -0.04 | |||||
Debt-to-Equity | -18.43 | |||||
Debt-to-EBITDA | 9.44 | |||||
Interest Coverage | 1.22 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 0.06 | |||||
Beneish M-Score | -2.47 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.6 | |||||
3-Year EBITDA Growth Rate | -2.6 | |||||
3-Year EPS without NRI Growth Rate | -53.2 | |||||
3-Year FCF Growth Rate | -1.2 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 5.84 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.19 | |||||
Quick Ratio | 0.82 | |||||
Cash Ratio | 0.14 | |||||
Days Inventory | 197.79 | |||||
Days Sales Outstanding | 77.79 | |||||
Days Payable | 81.84 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.9 | |||||
Shareholder Yield % | -47.17 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 70.8 | |||||
Operating Margin % | 18.65 | |||||
Net Margin % | -5.11 | |||||
FCF Margin % | 9.9 | |||||
ROA % | -1.77 | |||||
ROIC % | 10.55 | |||||
3-Year ROIIC % | -52.72 | |||||
ROC (Joel Greenblatt) % | 45.61 | |||||
ROCE % | 4.72 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 4.09 | |||||
Price-to-Owner-Earnings | 14.79 | |||||
PS Ratio | 0.33 | |||||
Price-to-Free-Cash-Flow | 3.38 | |||||
Price-to-Operating-Cash-Flow | 2.44 | |||||
EV-to-EBIT | 23.41 | |||||
EV-to-EBITDA | 10.62 | |||||
EV-to-Revenue | 2.69 | |||||
EV-to-FCF | 27.11 | |||||
Price-to-Projected-FCF | 0.61 | |||||
Price-to-Median-PS-Value | 0.39 | |||||
Earnings Yield (Greenblatt) % | 4.27 | |||||
FCF Yield % | 29.59 | |||||
Forward Rate of Return (Yacktman) % | 22.63 |